Literature DB >> 11472372

Reduced serum ceruloplasmin levels in hereditary haemochromatosis.

G Cairo1, D Conte, L Bianchi, M Fraquelli, S Recalcati.   

Abstract

As ceruloplasmin (Cp) seems to be involved in iron mobilization, serum Cp levels were measured in 35 patients with hereditary haemochromatosis (HH), 12 with acquired iron overload (AIO) and 36 healthy subjects. Cp was lower in HH patients than in controls (P < 0.001); no difference was found between untreated HH patients and those on a phlebotomy programme (P = 0.07) and between the HH patients carrying the normal and the mutated alleles of the HFE gene (P = 0.8). Cp levels in AIO subjects were significantly higher than in HH patients (P < 0.004) and similar to those of controls (P = 0.2). No differences in albumin, alpha1 acid glycoprotein and copper serum levels were observed in the three groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472372     DOI: 10.1046/j.1365-2141.2001.02917.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.

Authors:  Wen-Dong Tian; Jun-Zheng Li; Shui-Wang Hu; Xiao-Wei Peng; Gang Li; Xiong Liu; Huai-Hong Chen; Xia Xu; Xiang-Ping Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Transcuprein is a macroglobulin regulated by copper and iron availability.

Authors:  Nanmei Liu; Louis Shi-li Lo; S Hassan Askary; LaTrice Jones; Theodros Z Kidane; Trisha Trang; Minh Nguyen; Jeremy Goforth; Yu-Hsiang Chu; Esther Vivas; Monta Tsai; Terence Westbrook; Maria C Linder
Journal:  J Nutr Biochem       Date:  2007-03-23       Impact factor: 6.048

Review 3.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

4.  Bull's eye maculopathy associated with hereditary hemochromatosis.

Authors:  Kellyn N Bellsmith; Joshua L Dunaief; Paul Yang; Mark E Pennesi; Ellen Davis; Holly Hofkamp; Brandon J Lujan
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.